Nelson EA - Search Results

1

The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells.

D'Alo' F, Johansen LM, Nelson EA, Radomska HS, Evans EK, Zhang P, Nerlov C, Tenen DG. D'Alo' F, et al. Among authors: nelson ea. Blood. 2003 Nov 1;102(9):3163-71. doi: 10.1182/blood-2003-02-0479. Epub 2003 Jul 17. Blood. 2003. PMID: 12869508 Free article.

2

Induction of granulocytic differentiation by 2 pathways.

Zhang P, Nelson E, Radomska HS, Iwasaki-Arai J, Akashi K, Friedman AD, Tenen DG. Zhang P, et al. Blood. 2002 Jun 15;99(12):4406-12. doi: 10.1182/blood.v99.12.4406. Blood. 2002. PMID: 12036869 Free article.

3

Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3.

Nelson EA, Walker SR, Kepich A, Gashin LB, Hideshima T, Ikeda H, Chauhan D, Anderson KC, Frank DA. Nelson EA, et al. Blood. 2008 Dec 15;112(13):5095-102. doi: 10.1182/blood-2007-12-129718. Epub 2008 Sep 29. Blood. 2008. PMID: 18824601 Free PMC article.

4

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, Bellucci R, Raderschall E, Canning C, Soiffer RJ, Frank DA, Ritz J. Zorn E, et al. Among authors: nelson ea. Blood. 2006 Sep 1;108(5):1571-9. doi: 10.1182/blood-2006-02-004747. Epub 2006 Apr 27. Blood. 2006. PMID: 16645171 Free PMC article.

5

The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors.

Nelson EA, Walker SR, Weisberg E, Bar-Natan M, Barrett R, Gashin LB, Terrell S, Klitgaard JL, Santo L, Addorio MR, Ebert BL, Griffin JD, Frank DA. Nelson EA, et al. Blood. 2011 Mar 24;117(12):3421-9. doi: 10.1182/blood-2009-11-255232. Epub 2011 Jan 13. Blood. 2011. PMID: 21233313 Free PMC article.

6

Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells.

Weisberg E, Roesel J, Bold G, Furet P, Jiang J, Cools J, Wright RD, Nelson E, Barrett R, Ray A, Moreno D, Hall-Meyers E, Stone R, Galinsky I, Fox E, Gilliland G, Daley JF, Lazo-Kallanian S, Kung AL, Griffin JD. Weisberg E, et al. Blood. 2008 Dec 15;112(13):5161-70. doi: 10.1182/blood-2008-02-138065. Epub 2008 Sep 26. Blood. 2008. PMID: 18820131 Free PMC article.

7

STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.

Walker SR, Nelson EA, Frank DA. Walker SR, et al. Among authors: nelson ea. Oncogene. 2007 Jan 11;26(2):224-33. doi: 10.1038/sj.onc.1209775. Epub 2006 Jul 3. Oncogene. 2007. PMID: 16819511

8

Identification of human STAT5-dependent gene regulatory elements based on interspecies homology.

Nelson EA, Walker SR, Li W, Liu XS, Frank DA. Nelson EA, et al. J Biol Chem. 2006 Sep 8;281(36):26216-24. doi: 10.1074/jbc.M605001200. Epub 2006 Jul 13. J Biol Chem. 2006. PMID: 16840779 Free PMC article.

9

Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification.

Nelson EA, Walker SR, Alvarez JV, Frank DA. Nelson EA, et al. J Biol Chem. 2004 Dec 24;279(52):54724-30. doi: 10.1074/jbc.M408464200. Epub 2004 Oct 20. J Biol Chem. 2004. PMID: 15498775 Free article.

10

CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3.

Egusquiaguirre SP, Liu S, Tošić I, Jiang K, Walker SR, Nicolais M, Saw TY, Xiang M, Bartel K, Nelson EA, Frank DA. Egusquiaguirre SP, et al. Among authors: nelson ea. Neoplasia. 2020 Jan;22(1):47-59. doi: 10.1016/j.neo.2019.10.002. Epub 2019 Nov 22. Neoplasia. 2020. PMID: 31765941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

579 results

Search Page

Filters